Osteopenia Completed Phase 1 Trials for Romosozumab (DB11866)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00950950A Study to Evaluate the Effect of Romosozumab (AMG 785) on Bone Quality of the Forearm in Postmenopausal Women With Low Bone MassTreatment
NCT01059435A First-in-human Study Evaluating Romosozumab (AMG 785) in Healthy Men and Postmenopausal WomenTreatment
NCT01825785A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785)Treatment
NCT01101061A Single-dose Study Evaluating AMG 785 in Healthy Postmenopausal Japanese WomenTreatment